Crossmark

Drug Survival of Tumor Necrosis Factor-Alpha Inhibitors and Switched Subsequent Biologic Agents in Patients with Psoriasis: A Retrospective Study

Crossref DOI link: https://doi.org/10.1007/s13555-023-00932-0

Published Online: 2023-05-19

Published Print: 2023-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kishimoto, Megumi https://orcid.org/0000-0002-5136-1282
Komine, Mayumi https://orcid.org/0000-0002-1086-1803
Kamiya, Koji https://orcid.org/0000-0002-7938-1947
Sugai, Junichi

Kuwahara, Aya

Mieno, Makiko https://orcid.org/0000-0002-3510-9941
Ohtsuki, Mamitaro https://orcid.org/0000-0001-7845-6698
License Information

Text and Data Mining valid from 2023-05-19

Version of Record valid from 2023-05-19
More Information

Article History

Received: 16 February 2023

Accepted: 27 April 2023

First Online: 19 May 2023